Delivery Order SPE2DB24D8003-SPE2DB25FJTHC

Award Date 11/15/24
Potential Completion Date 11/18/24
Potential Value $16K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Anoka, MN, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
  • SPE2DB24D8003
    Indefinite Delivery Contract
  • SPE2DB24D8003-SPE2DB25FJTHC
    Delivery Order

The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price delivery order contract to Dakota Drug, Inc., a self-certified small disadvantaged business, for the purchase of WEGOVY 0.25 MG/0.5 ML PEN 0.5ML pharmaceutical products. The contract has a total ceiling value of $15,933.58 and a period of performance through November 18, 2024. Dakota Drug, Inc. holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical division under the ECAT Generation V Program, which allows the company to provide a comprehensive range of pharmaceutical and medical supply products to support U.S. Armed Forces medical operations. This most recent award is an unrestricted, non-set-aside contract, indicating Dakota Drug, Inc.'s competitive standing in the federal medical supply marketplace.

Generated 2/14/25, 9:26 AM